Stephanie Jung
Principal Investigator
Stephanie.jung@ukbonn.de
orcid:0000-0002-7409-9715
https://www.linkedin.com/in/stephanie-jung-3a2a741ba/?originalSubdomain=de
Stephanie holds a Diploma in Human Biology (Theoretical Medicine) from Philipps-University Marburg. In the framework of the Helmholtz Postdoctoral Program, she established her research focus on innate immunity, virology, RNA biology and extracellular vesicles. In October 2020, she was appointed junior professor and head of the „Cellular Virology“ working group at the Institute of Cardiovascular Immunology at the Universitätsklinikum Bonn.
Julia Steinberg
PhD candidate
julia2.steinberg@ukbonn.de
Julia holds a Master’s degree in Biochemistry and Molecular Biology from the Christian-Albrechts University to Kiel and started her Ph.D. thesis, embedded in the BIGS Immunosciences and Infection, in 2021. She works on the recognition of Hepatitis Delta Virus (HDV) infections by the innate immune system, as well as on the role of Extracellular Vesicles in HDV infection.
Laura Pearson
PhD candidate
laura.pearson@ukbonn.de
Laura studied Human Biology at the Philipps-Universty of Marburg with a focus on Virology. Her Ph.D. thesis, started in April of 2023, is concerned with the roll of Extracellular Vesicles during Hepatits B infections, as well as the innate immunological response to Hepatits B and D co-infections.
Maximillian Feige
PhD candidate
maximillian.feige@ukbonn.de
Maximillian obtained his Bachelor’s and Master’s degrees in Biochemistry at the Eberhard Karl University of Tübingen. There, he discovered his enthusiasm for immunology and took a special interest in the fields of virology and oncology. In September 2023, he started his Ph.D. project to investigate innate immune responses and antiviral signalling.
Timo Wadenpohl
Technicial assistant
timo.wadenpohl@ukbonn.de
.
Sven Kohrn
Master student
sven.kohrn@uni-bonn.de
Sven is currently finishing his Master´s degree in Medical Immunosciences and Infection at the University of Bonn. In his Master´s thesis project he is focussing on the immunomodulatory characteristics of Hepatits B Virus (HBV) during infection.